Pfizer Stock News

U.S. regulators on Friday put the brakes on their push to speed Pfizers COVID-19 to children under 5, creating major uncertainty about how soon the shots could become available.

FDA postpones key meeting, saying it needs to wait for data to show how well third Pfizer dose works for young children US regulators on Friday put the brakes on their push to speed Pfizer’s Covid vaccine to children under five, creating major uncertainty about how soon the shots could become available. The Food and Drug Administration had urged Pfizer and its partner BioNTech to apply for authorization of extra-low doses of its vaccine for the youngest children before studies were even finished – citing the toll the Omicron variant has taken on children. Continue reading…

The FDA is postponing an advisory committee meeting to wait for data on a third dose of Pfizer''s vaccine. That pushes back the timeline for potential approval.

U.S. regulators have put the brakes on their push to speed Pfizer’s COVID-19 to children under 5

The FDA''s vaccine experts were to consider emergency use authorization of Pfizer''s proposed vaccine for children 6 months through 4 years old on Feb. 15.

NEW YORK , Feb. 11, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AFRM, GDDY, DIS, PFE, and BABA. Full story available on Benzinga.com

A British Medical Journal investigation has found BioNTech, Pfizer’s partner on the main vaccine supplied in SA, allegedly tried to undermine efforts by the WHO

ABC News published this video item, entitled "Pfizer expected to release new data on COVID vaccine for kids under 5" - below is their description.

A European Medicines Agency safety committee is investigating cases of menstrual disorders seen with mRNA COVID-19 vaccines made by Pfizer /BioNTech and Moderna.

Drug behemoth Pfizer was the first to launch a Covid antiviral pill — but a pack of small biotech stocks are already nipping at its heels.

A decision by the agency on whether to authorize the shot is likely to come this month.

The European Medicines Agency''s safety committee said on Friday it was reviewing reports of heavy menstrual bleeding and absence of menstruation with COVID-19 vaccines from Pfizer/BioNTech and Moderna .

InvestorPlace - Stock Market News, Stock Advice & Trading Tips So, if you''re new to investing, which Robinhood stocks should you add to your portfolio? Keep these seven, all meeting the low-risk, reasonably priced criteria, on your watchlist as potential buys: Bank of America (NYSE:BAC) Ford (NYSE:F) Meta Platforms (NASDAQ:FB) General Electric (NYSE:GE) Alphabet (NASDAQ:GOOGL, NASDAQ:GOOG) Pfizer (NYSE:PFE) SPDR SPY 500 ETF (NYSEARCA:SPY) The post 7 Best Robinhood Stocks for Beginning Investors in 2022 appeared first on InvestorPlace . More From InvestorPlace Stock Prodigy Who Found NIO at $2 Says Buy THIS Now Man Who Called Black Monday: Prepare Now. #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First

Hardline Iranian President Ebrahim Raisi said on Friday Tehran never pins hope on ongoing talks in Vienna aimed at reviving the countrys 2015 nuclear agreement with world powers. Iran and Read more » The post Iranian President: Tehran Never Has Hope in Vienna Talks appeared first on Hamodia . In related news: Taliban Suicide Bombers Kill 27, Wound 40 in Attack on Afghan Police Romanian President Appoints Defense Minister as Interim PM RIA: Russia to Expand Black List of Americans in Response to Sanctions Monument to Holocaust Victims Vandalized in Ukraine Pfizer Seeks Conditional EU Authorization for COVID-19 Pill

Copyright 2022 NPR. To see more, visit https://www.npr.org.